Doerfler Douglas's Form 4 filing
Maxcyte, Inc. (MXCT) · filed Apr 12, 2023
- Accession no.
- 0001209191-23-024097
- Filed
- Apr 12, 2023, 4:37 PM ET
- Trade date
- Apr 10-12, 2023
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Checked
This filing lists 6 non-derivative transactions and 3 derivative transactions. Open-market sales total $75.0K. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Doerfler DouglasCIK 0001874482 | Director, Officer (President and CEO) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Apr 10, 2023 | Common Stock | MOption exerciseAcquired | +100 | $0.04 | +$4 | 333,297 | Direct | |
| Apr 10, 2023 | Common Stock | SSaleDisposed | −100 | $5.00 | −$500 | 333,197 | Direct | |
| Apr 11, 2023 | Common Stock | MOption exerciseAcquired | +2,182 | $0.04 | +$87.28 | 335,379 | Direct | |
| Apr 11, 2023 | Common Stock | SSaleDisposed | −2,182 | $5.00 | −$10,910 | 333,197 | Direct | |
| Apr 12, 2023 | Common Stock | MOption exerciseAcquired | +12,718 | $0.04 | +$508.72 | 345,915 | Direct | |
| Apr 12, 2023 | Common Stock | SSaleDisposed | −12,718 | $5.00 | −$63,590 | 333,197 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Apr 10, 2023 | Common Stock | MOption exerciseDisposed | −100 | $0.00 | $0 | 339,980 | Direct | |
| Apr 11, 2023 | Common Stock | MOption exerciseDisposed | −2,182 | $0.00 | $0 | 337,798 | Direct | |
| Apr 12, 2023 | Common Stock | MOption exerciseDisposed | −12,718 | $0.00 | $0 | 325,080 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.